Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 674

Similar articles for PubMed (Select 19779113)

1.

Breast cancer and cyclin D1 gene polymorphism in Turkish women.

Yaylim-Eraltan I, Ergen A, Görmüs U, Arikan S, Küçücük S, Sahin O, Yigit N, Yildiz Y, Isbir T.

In Vivo. 2009 Sep-Oct;23(5):767-72.

2.

The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.

Yaylim-Eraltan I, Arikan S, Yildiz Y, Cacina C, Ergen HA, Tuna G, Görmüs U, Zeybek U, Isbir T.

Anticancer Res. 2010 Jul;30(7):2875-80.

PMID:
20683026
3.

Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.

Rydzanicz M, Golusinski P, Mielcarek-Kuchta D, Golusinski W, Szyfter K.

Eur Arch Otorhinolaryngol. 2006 Jan;263(1):43-8. Epub 2005 Oct 29.

PMID:
16258756
4.

Association of cyclin D1 genotype with breast cancer risk and survival.

Shu XO, Moore DB, Cai Q, Cheng J, Wen W, Pierce L, Cai H, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):91-7.

5.

Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.

Yu CP, Yu JC, Sun CA, Tzao C, Ho JY, Yen AM.

Breast Cancer Res Treat. 2008 Jan;107(1):95-102. Epub 2007 Feb 15.

PMID:
18043898
6.

Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.

Bedewy AM, Mostafa MH, Saad AA, El-Maghraby SM, Bedewy MM, Hilal AM, Kandil LS.

J BUON. 2013 Jan-Mar;18(1):227-38.

PMID:
23613410
8.

Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.

Huang WS, Tang R, Lin PY, Changchien CR, Chen JS, Chiang JM, Yeh CY, Wang JY, Hsieh LL.

Dis Colon Rectum. 2006 May;49(5):602-8.

PMID:
16552496
9.

Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.

Gautschi O, Hugli B, Ziegler A, Bigosch C, Bowers NL, Ratschiller D, Jermann M, Stahel RA, Heighway J, Betticher DC.

Lung Cancer. 2006 Mar;51(3):303-11. Epub 2006 Jan 10.

PMID:
16406195
10.

Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.

Wang L, Habuchi T, Takahashi T, Mitsumori K, Kamoto T, Kakehi Y, Kakinuma H, Sato K, Nakamura A, Ogawa O, Kato T.

Carcinogenesis. 2002 Feb;23(2):257-64.

11.

GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China.

Jia A, Gong J, Li Y, Hao Z, Chang X, Dai F, Yu B.

Scand J Gastroenterol. 2008;43(11):1353-9. doi: 10.1080/00365520802158622.

PMID:
18609126
12.

CCND1 and CDKN1B polymorphisms and risk of breast cancer.

Canbay E, Eraltan IY, Cercel A, Isbir T, Gazioglu E, Aydogan F, Cacina C, Cengiz A, Ferahman M, Zengin E, Unal H.

Anticancer Res. 2010 Jul;30(7):3093-8.

PMID:
20683061
13.

CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.

Tüzüner BM, Oztürk T, Kisakesen HI, Ilvan S, Zerrin C, Oztürk O, Isbir T.

In Vivo. 2010 Jan-Feb;24(1):71-4.

PMID:
20133979
14.

Altered cyclin D1 genotype distribution in human sporadic pituitary adenomas.

Gazioglu NM, Erensoy N, Kadioglu P, Sayitoglu MA, Ersoy IH, Hatirnaz O, Kisacik B, Oz B, Sar M, Ozbek U, Ciplak N, Cagatay P.

Med Sci Monit. 2007 Oct;13(10):CR457-63.

PMID:
17901853
15.
16.

The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.

Tan XL, Nieters A, Kropp S, Hoffmeister M, Brenner H, Chang-Claude J.

Int J Cancer. 2008 Jun 1;122(11):2573-80. doi: 10.1002/ijc.23363.

PMID:
18196581
17.

CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.

Sathyan KM, Nalinakumari KR, Abraham T, Kannan S.

Oral Oncol. 2008 Jul;44(7):689-97. Epub 2007 Dec 3.

PMID:
18061526
18.

CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis.

Lu C, Dong J, Ma H, Jin G, Hu Z, Peng Y, Guo X, Wang X, Shen H.

Breast Cancer Res Treat. 2009 Aug;116(3):571-5. doi: 10.1007/s10549-008-0195-y. Epub 2008 Sep 26.

PMID:
18819000
19.

Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.

Yuan L, Gu X, Shao J, Wang M, Wang M, Zhu Q, Zhang Z.

DNA Cell Biol. 2010 Oct;29(10):611-7. doi: 10.1089/dna.2010.1018.

PMID:
20575692
20.

Cyclin D1 polymorphism and the risk of endometrial cancer.

Kang S, Kim JW, Park NH, Song YS, Kang SB, Lee HP.

Gynecol Oncol. 2005 May;97(2):431-5.

PMID:
15863141
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk